Address
Email address
Phone number
Website
https://www.tervistavstuudio.eeTervistav StuudioLoodus- ja alternatiivteraapiad ning tervisetoodete müük
Name
OÜ Terve Pere Stuudio
Registry code
11421590
VAT number
EE101179555
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
21.09.2007 (17)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
86909 - Other healthcare activities not classified elsewhere
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Helle Kullerkupp 18.12.1961 (62) | 100% - 2 556.00 EUR | Board member | Member of a higher management body, i.e. board member or supervisory board member | Founder |
| 2019 13.03.2021 | 2020 10.07.2021 | 2021 01.07.2022 | 2022 23.06.2023 | |
|---|---|---|---|---|
| Total Revenue | 47 260 € | 44 560 € | 50 769 € | 59 272 € |
| Net profit (loss) for the period | -973 € | -9 642 € | -2 937 € | 840 € |
| Profit Margin | -2% | -22% | -6% | 1% |
| Current Assets | 35 180 € | 36 098 € | 34 917 € | 36 143 € |
| Fixed Assets | 6 662 € | 6 662 € | 6 662 € | 6 662 € |
| Total Assets | 41 842 € | 42 760 € | 41 579 € | 42 805 € |
| Current Liabilities | 29 428 € | 35 596 € | 4 884 € | 5 412 € |
| Non Current Liabilities | 7 100 € | 11 492 € | 43 960 € | 43 775 € |
| Total Liabilities | 36 528 € | 47 088 € | 48 844 € | 49 187 € |
| Share Capital | - | - | - | - |
| Equity | 5 314 € | -4 328 € | -7 265 € | -6 382 € |
| Employees | 2 | 2 | 2 | 2 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 15 595.56 € | 2 657.03 € | 1 373.52 € | 3 |
| 2023 Q4 | 18 469.33 € | 2 696.68 € | 1 231.92 € | 3 |
| 2023 Q3 | 16 403.22 € | 3 442.01 € | 1 231.92 € | 3 |
| 2023 Q2 | 18 005.55 € | 1 948.16 € | 1 231.92 € | 3 |
| 2023 Q1 | 16 447.16 € | 2 424.43 € | 1 239.52 € | 3 |
| 2022 Q4 | 17 602.1 € | 2 671.82 € | 1 380.62 € | 3 |
| 2022 Q3 | 14 222.37 € | 3 173.89 € | 1 632.42 € | 3 |
| 2022 Q2 | 13 211.01 € | 1 965.71 € | 1 632.42 € | 2 |
| 2022 Q1 | 13 921.99 € | 2 643.79 € | 1 632.42 € | 2 |
| 2021 Q4 | 15 536.07 € | 2 354.34 € | 1 632.42 € | 2 |
| 2021 Q3 | 10 842.14 € | 2 459.78 € | 1 609.82 € | 2 |
| 2021 Q2 | 14 643.31 € | 2 363.21 € | 1 581.72 € | 2 |
| 2021 Q1 | 11 637.91 € | 2 647.58 € | 1 581.72 € | 2 |
| 2020 Q4 | 12 374.26 € | 2 379.45 € | 1 581.72 € | 2 |
| 2020 Q3 | 10 971.8 € | 2 193.76 € | 1 581.72 € | 2 |
| 2020 Q2 | 10 825.7 € | 1 651.16 € | 1 581.72 € | 2 |
| 2020 Q1 | 11 268.44 € | 2 137.99 € | 1 581.72 € | 2 |
